Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth (VIP)
Sponsor: Baystate Medical Center
This PHASE4 trial investigates Premature Birth and is currently completed. Baystate Medical Center leads this study, which shows 12 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE4
-
Sep 2025 — Feb 2026 [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Nov 2021 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
▶ Show 7 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Recruiting PHASE4
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Oct 2018 — Mar 2020 [monthly]
Recruiting PHASE4
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE4
-
May 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — May 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Sep 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baystate Medical Center
- George Washington University
- Ohio State University
- Thomas Jefferson University
- Vriginia Commonwealth University
For direct contact, visit the study record on ClinicalTrials.gov .